{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:44:58Z","timestamp":1795067098851,"version":"4.10.2"},"reference-count":259,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12035-023-03402-y","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T11:01:51Z","timestamp":1685962911000},"page":"5214-5236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Dysregulated MAD in Mad: A Neuro-theranostic Approach Through the Induction of Autophagic Biomarkers LC3B-II and ATG"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6980-6761","authenticated-orcid":false,"given":"Siva Prasad","family":"Panda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"3402_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/J.IJLP.2015.04.008","volume":"40","author":"H Pickard","year":"2015","unstructured":"Pickard H (2015) Choice, deliberation, violence: mental capacity and criminal responsibility in personality disorder. Int J Law Psychiatry 40:15. https:\/\/doi.org\/10.1016\/J.IJLP.2015.04.008","journal-title":"Int J Law Psychiatry"},{"key":"3402_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0972-6748.57851","volume":"18","author":"C Kiran","year":"2009","unstructured":"Kiran C, Chaudhury S (2009) Understanding delusions Ind Psychiatry J 18:3. https:\/\/doi.org\/10.4103\/0972-6748.57851","journal-title":"Understanding delusions Ind Psychiatry J"},{"key":"3402_CR3","doi-asserted-by":"publisher","unstructured":"Arvanitakis Z, Shah RC, Bennett DA (2019) Diagnosis and management of dementia: a review. J Am Med Assoc 322(16):1589\u20131599. https:\/\/doi.org\/10.1001\/jama.2019.4782","DOI":"10.1001\/jama.2019.4782"},{"key":"3402_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8720904","author":"G Ricci","year":"2019","unstructured":"Ricci G (2019). Social aspects of dementia prevention from a worldwide to national perspective: a review on the international situation and the example of Italy. https:\/\/doi.org\/10.1155\/2019\/8720904","journal-title":"Social aspects of dementia prevention from a worldwide to national perspective: a review on the international situation and the example of Italy"},{"key":"3402_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021412","author":"K Tori","year":"2020","unstructured":"Tori K, Kalligeros M, Nanda A et al (2020). Association between dementia and psychiatric disorders in long-term care residents an observational clinical study. https:\/\/doi.org\/10.1097\/MD.0000000000021412","journal-title":"Association between dementia and psychiatric disorders in long-term care residents an observational clinical study"},{"key":"3402_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/1567205011666140812115004","volume":"11","author":"RR Zilkens","year":"2014","unstructured":"Zilkens RR, Bruce DG, Duke J et al (2014) Send orders for reprints to reprints@benthamscience.net Severe psychiatric disorders in mid-life and risk of dementia in late-life (age 65\u201384 years): a population based case-control study. Curr Alzheimer Res 11:681\u2013693","journal-title":"Curr Alzheimer Res"},{"key":"3402_CR7","doi-asserted-by":"publisher","unstructured":"Luvsannyam E, Jain MS, Pormento MKL et al (2022) Neurobiology of schizophrenia: a comprehensive review. Cureus 14(4):23959. https:\/\/doi.org\/10.7759\/CUREUS.23959","DOI":"10.7759\/CUREUS.23959"},{"key":"3402_CR8","doi-asserted-by":"publisher","unstructured":"St\u0119pnicki P, Kondej M, Kaczor AA (2018) Current concepts and treatments of schizophrenia. Mol A J Synth Chem Nat Prod Chem 23(8):2087. https:\/\/doi.org\/10.3390\/MOLECULES23082087","DOI":"10.3390\/MOLECULES23082087"},{"key":"3402_CR9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/SCHBUL\/SBP059","volume":"36","author":"M Fink","year":"2010","unstructured":"Fink M, Shorter E, Taylor MA (2010) Catatonia Is not schizophrenia: Kraepelin\u2019s error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull 36:314. https:\/\/doi.org\/10.1093\/SCHBUL\/SBP059","journal-title":"Schizophr Bull"},{"key":"3402_CR10","first-page":"S52","volume":"51","author":"M Tripathi","year":"2009","unstructured":"Tripathi M, Vibha D (2009) Reversible dementias. Indian J Psychiatry 51:S52","journal-title":"Indian J Psychiatry"},{"key":"3402_CR11","doi-asserted-by":"publisher","unstructured":"Fountoulakis KN (2010) The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions. Ann Gen Psychiatry 9(14):1\u201322. https:\/\/doi.org\/10.1186\/1744-859X-9-14","DOI":"10.1186\/1744-859X-9-14"},{"key":"3402_CR12","first-page":"S29","volume":"51","author":"M Ganguli","year":"2009","unstructured":"Ganguli M (2009) Depression, cognitive impairment and dementia: why should clinicians care about the web of causation? Indian J Psychiatry 51:S29","journal-title":"Indian J Psychiatry"},{"key":"3402_CR13","first-page":"235","volume":"86","author":"A Banga","year":"2013","unstructured":"Banga A, Gyurmey T, Matuskey D et al (2013) Late-life onset bipolar disorder presenting as a case ofpseudo-dementia: a case discussion and review of literature. Yale J Biol Med 86:235","journal-title":"Yale J Biol Med"},{"key":"3402_CR14","doi-asserted-by":"publisher","unstructured":"Leung CCY, Gadelrab R, Ntephe CU et al (2019) Clinical course, neurobiology and therapeutic approaches to treatment resistant schizophrenia. Toward an integrated view. Front Psych 10:601. https:\/\/doi.org\/10.3389\/FPSYT.2019.00601\/BIBTEX","DOI":"10.3389\/FPSYT.2019.00601\/BIBTEX"},{"key":"3402_CR15","doi-asserted-by":"publisher","unstructured":"Cerejeira J, Lagarto L, Mukaetova-Ladinska EB (2012) Behavioral and psychological symptoms of dementia. Front Neurol 3(73):1\u201321. https:\/\/doi.org\/10.3389\/FNEUR.2012.00073","DOI":"10.3389\/FNEUR.2012.00073"},{"key":"3402_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.18773\/AUSTPRESCR.2015.071","volume":"38","author":"D Kitching","year":"2015","unstructured":"Kitching D (2015) Depression in dementia. . Aust Prescr 38:209. https:\/\/doi.org\/10.18773\/AUSTPRESCR.2015.071","journal-title":". Aust Prescr"},{"key":"3402_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/ARS.2013.5371","volume":"20","author":"KR Parzych","year":"2014","unstructured":"Parzych KR, Klionsky DJ (2014) An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal 20:460. https:\/\/doi.org\/10.1089\/ARS.2013.5371","journal-title":"Antioxid Redox Signal"},{"key":"3402_CR18","doi-asserted-by":"publisher","unstructured":"Khandia R, Dadar M, Munjal A et al (2019) A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy. Cells 8(7):674. https:\/\/doi.org\/10.3390\/CELLS8070674","DOI":"10.3390\/CELLS8070674"},{"key":"3402_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-00302-8_1","volume":"335","author":"Z Yang","year":"2009","unstructured":"Yang Z, Klionsky DJ (2009) An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol 335:1. https:\/\/doi.org\/10.1007\/978-3-642-00302-8_1","journal-title":"Curr Top Microbiol Immunol"},{"key":"3402_CR20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/SCIENCE.1201940","volume":"333","author":"DR Green","year":"2011","unstructured":"Green DR, Galluzzi L, Kroemer G (2011) Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 333:1109. https:\/\/doi.org\/10.1126\/SCIENCE.1201940","journal-title":"Science"},{"key":"3402_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/ANNUREV-CLINPSY-082719-104030","volume":"16","author":"TE Daniels","year":"2020","unstructured":"Daniels TE, Olsen EM, Tyrka AR (2020) Stress and psychiatric disorders: the role of mitochondria. Annu Rev Clin Psychol 16:165. https:\/\/doi.org\/10.1146\/ANNUREV-CLINPSY-082719-104030","journal-title":"Annu Rev Clin Psychol"},{"key":"3402_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/PSY.0000000000000544","volume":"80","author":"M Picard","year":"2018","unstructured":"Picard M, McEwen BS (2018) Psychological stress and mitochondria: a conceptual framework. Psychosom Med 80:126. https:\/\/doi.org\/10.1097\/PSY.0000000000000544","journal-title":"Psychosom Med"},{"key":"3402_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/PSY.0000000000000545","volume":"80","author":"M Picard","year":"2018","unstructured":"Picard M, McEwen BS (2018) Psychological stress and mitochondria: a systematic review. Psychosom Med 80:141. https:\/\/doi.org\/10.1097\/PSY.0000000000000545","journal-title":"Psychosom Med"},{"key":"3402_CR24","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1007\/s00018-021-03887-7","volume":"78","author":"E-M Eckl","year":"2021","unstructured":"Eckl E-M, Ziegemann O, Krumwiede L et al (2021) Sensing, signaling and surviving mitochondrial stress. Cell Mol Life Sci 78:5925\u20135951. https:\/\/doi.org\/10.1007\/s00018-021-03887-7","journal-title":"Cell Mol Life Sci"},{"key":"3402_CR25","doi-asserted-by":"publisher","unstructured":"Cai Q, Jeong YY (2020) Mitophagy in Alzheimer\u2019s disease and other age-related neurodegenerative diseases. Cells 9(1):150. https:\/\/doi.org\/10.3390\/CELLS9010150","DOI":"10.3390\/CELLS9010150"},{"key":"3402_CR26","doi-asserted-by":"publisher","unstructured":"Bernstein HG, Keilhoff G, Dobrowolny H, Steiner J (2020) Enhanced mitochondrial autophagy (mitophagy) in oligodendrocytes might play a role in white matter pathology in schizophrenia. Med Hypotheses 134:109443. https:\/\/doi.org\/10.1016\/J.MEHY.2019.109443","DOI":"10.1016\/J.MEHY.2019.109443"},{"key":"3402_CR27","doi-asserted-by":"publisher","unstructured":"Di Meo S, Reed TT, Venditti P, Victor VM (2016) Role of ROS and RNS sources in physiological and pathological conditions. Oxid Med Cell Longev 2016:1245049. https:\/\/doi.org\/10.1155\/2016\/1245049","DOI":"10.1155\/2016\/1245049"},{"key":"3402_CR28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/PHYSREV.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94:909. https:\/\/doi.org\/10.1152\/PHYSREV.00026.2013","journal-title":"Physiol Rev"},{"key":"3402_CR29","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.249218","author":"J Jung","year":"2019","unstructured":"Jung J, Huh Y, Shefa U et al (2019). Mitophagy links oxidative stress conditions and neurodegenerative diseases. https:\/\/doi.org\/10.4103\/1673-5374.249218","journal-title":"Mitophagy links oxidative stress conditions and neurodegenerative diseases"},{"key":"3402_CR30","doi-asserted-by":"publisher","unstructured":"Li S, Zhang J, Liu C et al (2021) The role of mitophagy in regulating cell death. Oxid Med Cell Longev 2021:6617256. https:\/\/doi.org\/10.1155\/2021\/6617256","DOI":"10.1155\/2021\/6617256"},{"key":"3402_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.MITO.2022.07.002","volume":"66","author":"SP Panda","year":"2022","unstructured":"Panda SP, Dhurandhar Y, Agrawal M (2022) The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): a review of therapeutic approaches. Mitochondrion 66:27\u201337. https:\/\/doi.org\/10.1016\/J.MITO.2022.07.002","journal-title":"Mitochondrion"},{"key":"3402_CR32","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.3390\/IJMS22083903","volume":"22","author":"L Doblado","year":"2021","unstructured":"Doblado L, Lueck C, Rey C et al (2021) Mitophagy in human diseases. Int J Mol Sci 22:3903. https:\/\/doi.org\/10.3390\/IJMS22083903","journal-title":"Int J Mol Sci"},{"key":"3402_CR33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2174\/138161210790361461","volume":"16","author":"RB Mailman","year":"2010","unstructured":"Mailman RB, Murthy V (2010) Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr Pharm Des 16:488\u2013501","journal-title":"Curr Pharm Des"},{"key":"3402_CR34","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/CELLS10051228","volume":"10","author":"T Boczek","year":"2021","unstructured":"Boczek T, Mackiewicz J, Sobolczyk M et al (2021) The role of G protein-coupled receptors (GPCRs) and calcium signaling in schizophrenia. Focus on GPCRs activated by neurotransmitters and chemokines. Cells 10:1228. https:\/\/doi.org\/10.3390\/CELLS10051228","journal-title":"Cells"},{"key":"3402_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/1574886314666190301152734","volume":"14","author":"J Read","year":"2019","unstructured":"Read J, Williams J (2019) Current Drug Safety Current Drug Safety Send Orders for Reprints to reprints@benthamscience.net Positive and negative effects of antipsychotic medication: an interna-tional online survey of 832 recipients. Curr Drug Saf 14:173\u2013181. https:\/\/doi.org\/10.2174\/1574886314666190301152734","journal-title":"Curr Drug Saf"},{"key":"3402_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2217\/pgs-2018-0163","volume":"20","author":"JD Allen","year":"2019","unstructured":"Allen JD, Bishop JR (2019) A systematic review of genome-wide association studies of antipsychotic response. Pharmacogenomics 20:291\u2013306. https:\/\/doi.org\/10.2217\/pgs-2018-0163","journal-title":"Pharmacogenomics"},{"key":"3402_CR37","doi-asserted-by":"publisher","unstructured":"Wahbeh MH, Avramopoulos D (2021) Gene-environment interactions in schizophrenia: a literature review. Genes (Basel) 12:1\u201313. https:\/\/doi.org\/10.3390\/GENES12121850","DOI":"10.3390\/GENES12121850"},{"key":"3402_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.9758\/CPN.2020.18.1.10","volume":"18","author":"J Hong","year":"2020","unstructured":"Hong J, Bang M (2020) Anti-inflammatory strategies for schizophrenia: a review of evidence for therapeutic applications and drug repurposing. Clin Psychopharmacol Neurosci 18:10. https:\/\/doi.org\/10.9758\/CPN.2020.18.1.10","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"3402_CR39","doi-asserted-by":"publisher","unstructured":"Zhuo C, Xu Y, Hou W et al (2022) Mechanistic\/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy. Transl Psychiatry 12(1):1\u20138. https:\/\/doi.org\/10.1038\/S41398-021-01778-W","DOI":"10.1038\/S41398-021-01778-W"},{"key":"3402_CR40","doi-asserted-by":"publisher","unstructured":"Bar-Yosef T, Damri O, Agam G (2019) Dual role of autophagy in diseases of the central nervous system. Front Cell Neurosci 13(196):1\u201314. https:\/\/doi.org\/10.3389\/FNCEL.2019.00196","DOI":"10.3389\/FNCEL.2019.00196"},{"key":"3402_CR41","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1089\/NEU.2011.1919","volume":"29","author":"A Sekiguchi","year":"2012","unstructured":"Sekiguchi A, Kanno H, Ozawa H et al (2012) Rapamycin promotes autophagy and reduces neural tissue damage and locomotor impairment after spinal cord injury in mice. J Neurotrauma 29:946\u2013956. https:\/\/doi.org\/10.1089\/NEU.2011.1919","journal-title":"J Neurotrauma"},{"key":"3402_CR42","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1111\/BPH.12792","volume":"171","author":"F Gros","year":"2014","unstructured":"Gros F, Muller S (2014) Pharmacological regulators of autophagy and their link with modulators of lupus disease. Br J Pharmacol 171:4337. https:\/\/doi.org\/10.1111\/BPH.12792","journal-title":"Br J Pharmacol"},{"key":"3402_CR43","doi-asserted-by":"publisher","unstructured":"Sciarretta S, Zhai P, Volpe M, Sadoshima J (2012) Pharmacological modulation of autophagy during cardiac stress. J Cardiovasc Pharmacol 60:235\u2013241. https:\/\/doi.org\/10.1097\/FJC.0B013E3182575F61","DOI":"10.1097\/FJC.0B013E3182575F61"},{"key":"3402_CR44","doi-asserted-by":"publisher","first-page":"13304","DOI":"10.1021\/ACSAMI.7B01735","volume":"9","author":"MH Chen","year":"2017","unstructured":"Chen MH, Wang FX, Cao JJ et al (2017) Light-up mitophagy in live cells with dual-functional theranostic phosphorescent iridium(III) complexes. ACS Appl Mater Interfaces 9:13304\u201313314. https:\/\/doi.org\/10.1021\/ACSAMI.7B01735","journal-title":"ACS Appl Mater Interfaces"},{"key":"3402_CR45","doi-asserted-by":"publisher","unstructured":"Dayem AA, Hossain MK, Lee S Bin et al (2017) The role of reactive oxygen species (ROS) in the biological activities of metallic nanoparticles. Int J Mol Sci 18(1):1\u201321. https:\/\/doi.org\/10.3390\/IJMS18010120","DOI":"10.3390\/IJMS18010120"},{"key":"3402_CR46","doi-asserted-by":"publisher","unstructured":"Lunova M, Smolkov\u00e1 B, Lynnyk A et al (2019) Targeting the mTOR signaling pathway utilizing nanoparticles: a critical overview. Cancers (Basel) 11(1):1\u201318. https:\/\/doi.org\/10.3390\/CANCERS11010082","DOI":"10.3390\/CANCERS11010082"},{"key":"3402_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.07.009","author":"J Xie","year":"2010","unstructured":"Xie J, Lee S, Chen X (2010). Nanoparticle-based theranostic agents. https:\/\/doi.org\/10.1016\/j.addr.2010.07.009","journal-title":"Nanoparticle-based theranostic agents"},{"key":"3402_CR48","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2147\/IJN.S299448","volume":"16","author":"H Zare","year":"2021","unstructured":"Zare H, Ahmadi S, Ghasemi A et al (2021) Carbon nanotubes: smart drug\/gene delivery carriers. Int J Nanomedicine 16:1681. https:\/\/doi.org\/10.2147\/IJN.S299448","journal-title":"Int J Nanomedicine"},{"issue":"15","key":"3402_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S11671-020-03344-7","volume":"151","author":"Z Yu","year":"2020","unstructured":"Yu Z, Li Q, Wang J et al (2020) Reactive oxygen species-related nanoparticle toxicity in the biomedical field. Nanoscale Res Lett 151(15):1\u201314. https:\/\/doi.org\/10.1186\/S11671-020-03344-7","journal-title":"Nanoscale Res Lett"},{"key":"3402_CR50","doi-asserted-by":"publisher","first-page":"21859","DOI":"10.1021\/AM5036225","volume":"6","author":"BT Luk","year":"2014","unstructured":"Luk BT, Zhang L (2014) Currentadvances in polymer-based nanotheranosticsfor cancer treatment and diagnosis. ACS Appl Mater Interfaces 6:21859. https:\/\/doi.org\/10.1021\/AM5036225","journal-title":"ACS Appl Mater Interfaces"},{"key":"3402_CR51","doi-asserted-by":"publisher","unstructured":"Gheorghita R, Anchidin-Norocel L, Filip R et al (2021) Applications of biopolymers for drugs and probiotics delivery. Polymers (Basel) 13(16):2729. https:\/\/doi.org\/10.3390\/POLYM13162729","DOI":"10.3390\/POLYM13162729"},{"key":"3402_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/NANO10071403","volume":"10","author":"B Begines","year":"2020","unstructured":"Begines B, Ortiz T, P\u00e9rez-Aranda M et al (2020) Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials 10:1\u201341. https:\/\/doi.org\/10.3390\/NANO10071403","journal-title":"Nanomaterials"},{"key":"3402_CR53","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/JPHP.13098","volume":"71","author":"MF Attia","year":"2019","unstructured":"Attia MF, Anton N, Wallyn J et al (2019) An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol 71:1185\u20131198. https:\/\/doi.org\/10.1111\/JPHP.13098","journal-title":"J Pharm Pharmacol"},{"key":"3402_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2012.12.006","author":"SD Steichen","year":"2012","unstructured":"Steichen SD, Caldorera-Moore M, Peppas NA (2012). A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. https:\/\/doi.org\/10.1016\/j.ejps.2012.12.006","journal-title":"A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics"},{"key":"3402_CR55","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/JPM11060571","volume":"11","author":"MA Subhan","year":"2021","unstructured":"Subhan MA, Yalamarty SSK, Filipczak N et al (2021) Recent advances in tumor targeting via EPR effect for cancer treatment. J Pers Med 11:571. https:\/\/doi.org\/10.3390\/JPM11060571","journal-title":"J Pers Med"},{"key":"3402_CR56","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4161\/AUTO.28175","volume":"10","author":"LJ Kraft","year":"2014","unstructured":"Kraft LJ, Nguyen TA, Vogel SS, Kenworthy AK (2014) Size, stoichiometry, and organization of soluble LC3-associated complexes. Autophagy 10:861. https:\/\/doi.org\/10.4161\/AUTO.28175","journal-title":"Autophagy"},{"key":"3402_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","volume":"445","author":"I Tanida","year":"2008","unstructured":"Tanida I, Ueno T, Kominami E (2008) LC3 and autophagy. Methods Mol Biol 445:77\u201388. https:\/\/doi.org\/10.1007\/978-1-59745-157-4_4","journal-title":"Methods Mol Biol"},{"key":"3402_CR58","doi-asserted-by":"publisher","unstructured":"Koukourakis MI, Kalamida D, Giatromanolaki A et al (2015) Autophagosome proteins LC3A, LC3B and LC3C have distinct subcellular distribution kinetics and expression in cancer cell lines. PLoS One 10(9):1\u201313. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0137675","DOI":"10.1371\/JOURNAL.PONE.0137675"},{"key":"3402_CR59","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/J.BIOCEL.2004.05.009","volume":"36","author":"I Tanida","year":"2004","unstructured":"Tanida I, Ueno T, Kominami E (2004) LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36:2503. https:\/\/doi.org\/10.1016\/J.BIOCEL.2004.05.009","journal-title":"Int J Biochem Cell Biol"},{"key":"3402_CR60","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.4161\/AUTO.29468","volume":"10","author":"J Dancourt","year":"2014","unstructured":"Dancourt J, Melia TJ (2014) Lipidation of the autophagy proteins LC3 and GABARAP is a membrane-curvature dependent process. Autophagy 10:1470. https:\/\/doi.org\/10.4161\/AUTO.29468","journal-title":"Autophagy"},{"key":"3402_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-1-4939-2522-3_10","volume":"1292","author":"MN Sharifi","year":"2015","unstructured":"Sharifi MN, Mowers EE, Drake LE, Macleod KF (2015) Measuring autophagy in stressed cells. Methods Mol Biol 1292:129. https:\/\/doi.org\/10.1007\/978-1-4939-2522-3_10","journal-title":"Methods Mol Biol"},{"key":"3402_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/J.CELL.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140:313. https:\/\/doi.org\/10.1016\/J.CELL.2010.01.028","journal-title":"Cell"},{"key":"3402_CR63","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/15548627.2019.1569925","volume":"15","author":"A Agrotis","year":"2019","unstructured":"Agrotis A, Pengo N, Burden JJ, Ketteler R (2019) Redundancy of human ATG4 protease isoforms in autophagy and LC3\/GABARAP processing revealed in cells. Autophagy 15:976. https:\/\/doi.org\/10.1080\/15548627.2019.1569925","journal-title":"Autophagy"},{"key":"3402_CR64","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.15252\/EMBJ.201696315","volume":"36","author":"Y Lee","year":"2017","unstructured":"Lee Y, Jun Y, Choi H et al (2017) Development of LC3\/GABARAP sensors containing a LIR and a hydrophobic domain to monitor autophagy. EMBO J 36:1100. https:\/\/doi.org\/10.15252\/EMBJ.201696315","journal-title":"EMBO J"},{"key":"3402_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/CSHPERSPECT.A008813","volume":"4","author":"G Das","year":"2012","unstructured":"Das G, Shravage BV, Baehrecke EH (2012) Regulation and function of autophagy during cell survival and cell death. Cold Spring Harb Perspect Biol 4:1\u201314. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A008813","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3402_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4161\/AUTO.7.3.14487","volume":"7","author":"T Johansen","year":"2011","unstructured":"Johansen T, Lamark T (2011) Selective autophagy mediated by autophagic adapter proteins. Autophagy 7:279. https:\/\/doi.org\/10.4161\/AUTO.7.3.14487","journal-title":"Autophagy"},{"key":"3402_CR67","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4161\/AUTO.4600","volume":"3","author":"N Mizushima","year":"2007","unstructured":"Mizushima N, Yoshimori T (2007) How to interpret LC3 immunoblotting. Autophagy 3:542\u2013545. https:\/\/doi.org\/10.4161\/AUTO.4600","journal-title":"Autophagy"},{"key":"3402_CR68","doi-asserted-by":"publisher","first-page":"26549","DOI":"10.1074\/JBC.M115.658088","volume":"290","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wilkie-Grantham RP, Yanagi T et al (2015) ATG4B (Autophagin-1) phosphorylation modulates autophagy. J Biol Chem 290:26549. https:\/\/doi.org\/10.1074\/JBC.M115.658088","journal-title":"J Biol Chem"},{"key":"3402_CR69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-12-416618-9.00002-9","volume":"542","author":"J Goldsmith","year":"2014","unstructured":"Goldsmith J, Levine B, Debnath J (2014) Autophagy and cancer metabolism. Methods Enzymol 542:25\u201357. https:\/\/doi.org\/10.1016\/B978-0-12-416618-9.00002-9","journal-title":"Methods Enzymol"},{"key":"3402_CR70","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1080\/15548627.2021.1874132","volume":"17","author":"N Vuji\u0107","year":"2021","unstructured":"Vuji\u0107 N, Bradi\u0107 I, Goeritzer M et al (2021) ATG7 is dispensable for LC3-PE conjugation in thioglycolate-elicited mouse peritoneal macrophages. Autophagy 17:3402\u20133407. https:\/\/doi.org\/10.1080\/15548627.2021.1874132","journal-title":"Autophagy"},{"key":"3402_CR71","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4161\/AUTO.22931","volume":"9","author":"M Walczak","year":"2013","unstructured":"Walczak M, Martens S (2013) Dissecting the role of the Atg12\u2013Atg5-Atg16 complex during autophagosome formation. Autophagy 9:424. https:\/\/doi.org\/10.4161\/AUTO.22931","journal-title":"Autophagy"},{"key":"3402_CR72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/NSMB.2431","volume":"20","author":"C Otomo","year":"2013","unstructured":"Otomo C, Metlagel Z, Takaesu G, Otomo T (2013) Structure of the human ATG12~ATG5 conjugate required for LC3 lipidation in autophagy. Nat Struct Mol Biol 20:59. https:\/\/doi.org\/10.1038\/NSMB.2431","journal-title":"Nat Struct Mol Biol"},{"key":"3402_CR73","doi-asserted-by":"publisher","first-page":"24131","DOI":"10.1074\/JBC.M702824200","volume":"282","author":"S Pankiv","year":"2007","unstructured":"Pankiv S, Clausen TH, Lamark T et al (2007) p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282:24131\u201324145. https:\/\/doi.org\/10.1074\/JBC.M702824200","journal-title":"J Biol Chem"},{"key":"3402_CR74","doi-asserted-by":"publisher","unstructured":"Hwang HJ, Ha H, Lee BS et al (2022) LC3B is an RNA-binding protein to trigger rapid mRNA degradation during autophagy. Nat Commun 13(1):1\u201317. https:\/\/doi.org\/10.1038\/S41467-022-29139-1","DOI":"10.1038\/S41467-022-29139-1"},{"key":"3402_CR75","doi-asserted-by":"publisher","unstructured":"Hwang HJ, Kim YK (2023) The role of LC3B in autophagy as an RNA-binding protein. Autophagy 19(3):1028\u20131030. https:\/\/doi.org\/10.1080\/15548627.2022.2111083","DOI":"10.1080\/15548627.2022.2111083"},{"key":"3402_CR76","doi-asserted-by":"publisher","unstructured":"Kim H, Seong J (2021) Fluorescent protein-based autophagy biosensors. Materials (Basel) 14(11):3019. https:\/\/doi.org\/10.3390\/MA14113019","DOI":"10.3390\/MA14113019"},{"key":"3402_CR77","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/NBT1095","volume":"23","author":"TA Kost","year":"2005","unstructured":"Kost TA, Condreay JP, Jarvis DL (2005) Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23:567. https:\/\/doi.org\/10.1038\/NBT1095","journal-title":"Nat Biotechnol"},{"key":"3402_CR78","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/978-1-60761-999-4_34","volume":"698","author":"M O\u2019Grady","year":"2011","unstructured":"O\u2019Grady M, Batchelor RH, Scheyhing K et al (2011) BacMam-mediated gene delivery into multipotent mesenchymal stromal cells. Methods Mol Biol 698:485\u2013504. https:\/\/doi.org\/10.1007\/978-1-60761-999-4_34","journal-title":"Methods Mol Biol"},{"key":"3402_CR79","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/J.BIOTECHADV.2011.04.004","volume":"29","author":"CY Chen","year":"2011","unstructured":"Chen CY, Lin CY, Chen GY, Hu YC (2011) Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv 29:618. https:\/\/doi.org\/10.1016\/J.BIOTECHADV.2011.04.004","journal-title":"Biotechnol Adv"},{"key":"3402_CR80","doi-asserted-by":"publisher","unstructured":"Levin E, Diekmann H, Fischer D (2016) Highly efficient transduction of primary adult CNS and PNS neurons. Sci Rep 6:38928. https:\/\/doi.org\/10.1038\/SREP38928","DOI":"10.1038\/SREP38928"},{"key":"3402_CR81","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/15548627.2016.1243199","volume":"13","author":"DH Kwon","year":"2017","unstructured":"Kwon DH, Kim S, Jung YO et al (2017) The 1:2 complex between RavZ and LC3 reveals a mechanism for deconjugation of LC3 on the phagophore membrane. Autophagy 13:70. https:\/\/doi.org\/10.1080\/15548627.2016.1243199","journal-title":"Autophagy"},{"key":"3402_CR82","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/BIORES.2015.0018","volume":"4","author":"T Tsukahara","year":"2015","unstructured":"Tsukahara T, Haniu H, Matsuda Y (2015) The PTB-associated splicing factor\/peroxisome proliferator-activated receptor gamma axis regulates autophagosome formation in human pancreatic cancer cells. Biores Open Access 4:319. https:\/\/doi.org\/10.1089\/BIORES.2015.0018","journal-title":"Biores Open Access"},{"key":"3402_CR83","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, Orhon I, Rocchi C et al (2018) Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14:1435. https:\/\/doi.org\/10.1080\/15548627.2018.1474314","journal-title":"Autophagy"},{"key":"3402_CR84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/BS.MIE.2016.09.052","volume":"587","author":"LS Frost","year":"2017","unstructured":"Frost LS, Dhingra A, Reyes-Reveles J, Boesze-Battaglia K (2017) The use of DQ-BSA to monitor the turnover of autophagy-associated cargo. Methods Enzymol 587:43\u201354. https:\/\/doi.org\/10.1016\/BS.MIE.2016.09.052","journal-title":"Methods Enzymol"},{"key":"3402_CR85","doi-asserted-by":"publisher","unstructured":"Zhang Z, Singh R, Aschner M (2016) Methods for the detection of autophagy in mammalian cells. Curr Protoc Toxicol 69:1\u201320. https:\/\/doi.org\/10.1002\/CPTX.11","DOI":"10.1002\/CPTX.11"},{"key":"3402_CR86","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/J.NEUINT.2017.02.007","volume":"109","author":"EM Fivenson","year":"2017","unstructured":"Fivenson EM, Lautrup S, Sun N et al (2017) Mitophagy in neurodegeneration and aging. Neurochem Int 109:202. https:\/\/doi.org\/10.1016\/J.NEUINT.2017.02.007","journal-title":"Neurochem Int"},{"key":"3402_CR87","doi-asserted-by":"publisher","unstructured":"Tran M, Reddy PH (2020) Defective autophagy and mitophagy in aging and Alzheimer\u2019s disease. Front Neurosci 14:612757. https:\/\/doi.org\/10.3389\/FNINS.2020.612757","DOI":"10.3389\/FNINS.2020.612757"},{"key":"3402_CR88","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/J.CEB.2004.09.012","volume":"16","author":"RV Rao","year":"2004","unstructured":"Rao RV, Bredesen DE (2004) Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr Opin Cell Biol 16:653. https:\/\/doi.org\/10.1016\/J.CEB.2004.09.012","journal-title":"Curr Opin Cell Biol"},{"key":"3402_CR89","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/J.BBI.2020.10.007","volume":"91","author":"L Li","year":"2021","unstructured":"Li L, Acioglu C, Heary RF, Elkabes S (2021) Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun 91:740. https:\/\/doi.org\/10.1016\/J.BBI.2020.10.007","journal-title":"Brain Behav Immun"},{"key":"3402_CR90","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1042\/CS20110164","volume":"121","author":"ML Hanke","year":"2011","unstructured":"Hanke ML, Kielian T (2011) Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) 121:367. https:\/\/doi.org\/10.1042\/CS20110164","journal-title":"Clin Sci (Lond)"},{"key":"3402_CR91","doi-asserted-by":"publisher","first-page":"16162","DOI":"10.1074\/JBC.M116.714923","volume":"291","author":"S Akabane","year":"2016","unstructured":"Akabane S, Matsuzaki K, Yamashita SI et al (2016) Constitutive activation of PINK1 protein leads to proteasome-mediated and non-apoptotic cell death independently of mitochondrial autophagy. J Biol Chem 291:16162. https:\/\/doi.org\/10.1074\/JBC.M116.714923","journal-title":"J Biol Chem"},{"key":"3402_CR92","doi-asserted-by":"publisher","unstructured":"McLelland GL, Goiran T, Yi W et al (2018) Mfn2 ubiquitination by PINK1\/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy. Elife 7:1\u201335. https:\/\/doi.org\/10.7554\/ELIFE.32866","DOI":"10.7554\/ELIFE.32866"},{"key":"3402_CR93","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/AUTO.7.2.14332","volume":"7","author":"ME Gegg","year":"2011","unstructured":"Gegg ME, Schapira AHV (2011) PINK1-parkin-dependent mitophagy involves ubiquitination of mitofusins 1 and 2: implications for Parkinson disease pathogenesis. Autophagy 7:243. https:\/\/doi.org\/10.4161\/AUTO.7.2.14332","journal-title":"Autophagy"},{"key":"3402_CR94","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15548627.2021.1888244","volume":"18","author":"P Tere\u0161ak","year":"2022","unstructured":"Tere\u0161ak P, Lapao A, Subic N et al (2022) Regulation of PRKN-independent mitophagy. Autophagy 18:24. https:\/\/doi.org\/10.1080\/15548627.2021.1888244","journal-title":"Autophagy"},{"key":"3402_CR95","doi-asserted-by":"publisher","unstructured":"Park SY, Koh HC (2020) FUNDC1 regulates receptor-mediated mitophagy independently of the PINK1\/Parkin-dependent pathway in rotenone-treated SH-SY5Y cells. Food Chem Toxicol 137:111163. https:\/\/doi.org\/10.1016\/J.FCT.2020.111163","DOI":"10.1016\/J.FCT.2020.111163"},{"key":"3402_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.MITO.2021.08.016","volume":"61","author":"A Tripathi","year":"2021","unstructured":"Tripathi A, Sciani G, Barichello T et al (2021) Mitophagy in depression: pathophysiology and treatment targets. Mitochondrion 61:1\u201310. https:\/\/doi.org\/10.1016\/J.MITO.2021.08.016","journal-title":"Mitochondrion"},{"key":"3402_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/PHARMACEUTICS12111083","volume":"12","author":"E Bottani","year":"2020","unstructured":"Bottani E, Lamperti C, Prigione A et al (2020) Therapeutic approaches to treat mitochondrial diseases: \u201cone-size-fits-all\u201d and \u201cprecision medicine\u201d strategies. Pharmaceutics 12:1\u201363. https:\/\/doi.org\/10.3390\/PHARMACEUTICS12111083","journal-title":"Pharmaceutics"},{"key":"3402_CR98","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1021\/ACSCHEMBIO.7B00647","volume":"12","author":"H Iwashita","year":"2017","unstructured":"Iwashita H, Torii S, Nagahora N et al (2017) Live cell imaging of mitochondrial autophagy with a novel fluorescent small molecule. ACS Chem Biol 12:2546\u20132551. https:\/\/doi.org\/10.1021\/ACSCHEMBIO.7B00647","journal-title":"ACS Chem Biol"},{"key":"3402_CR99","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/J.MOLMED.2019.09.009","volume":"26","author":"B Glancy","year":"2020","unstructured":"Glancy B (2020) Visualizing mitochondrial form and function within the cell. Trends Mol Med 26:58. https:\/\/doi.org\/10.1016\/J.MOLMED.2019.09.009","journal-title":"Trends Mol Med"},{"key":"3402_CR100","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-1-61779-328-8_21","volume":"793","author":"J Zhu","year":"2011","unstructured":"Zhu J, Dagda RK, Chu CT (2011) Monitoring mitophagy in neuronal cell cultures. Methods Mol Biol 793:325. https:\/\/doi.org\/10.1007\/978-1-61779-328-8_21","journal-title":"Methods Mol Biol"},{"key":"3402_CR101","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1080\/15548627.2021.1907167","volume":"17","author":"S Han","year":"2021","unstructured":"Han S, Zhang M, Jeong YY et al (2021) The role of mitophagy in the regulation of mitochondrial energetic status in neurons. Autophagy 17:4182. https:\/\/doi.org\/10.1080\/15548627.2021.1907167","journal-title":"Autophagy"},{"key":"3402_CR102","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/J.1472-8206.2012.01071.X","volume":"28","author":"E Jouan","year":"2014","unstructured":"Jouan E, Le Vee M, Denizot C et al (2014) The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2. Fundam Clin Pharmacol 28:65\u201377. https:\/\/doi.org\/10.1111\/J.1472-8206.2012.01071.X","journal-title":"Fundam Clin Pharmacol"},{"key":"3402_CR103","doi-asserted-by":"publisher","unstructured":"Mitra K, Lippincott-Schwartz J (2010) Analysis of mitochondrial dynamics and functions using imaging approaches. Curr Protoc Cell Biol 46(1):4\u201325. https:\/\/doi.org\/10.1002\/0471143030.CB0425S46","DOI":"10.1002\/0471143030.CB0425S46"},{"key":"3402_CR104","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1101\/PDB.PROT5648","volume":"2011","author":"B Chazotte","year":"2011","unstructured":"Chazotte B (2011) Labeling mitochondria with MitoTracker dyes. Cold Spring Harb Protoc 2011:990\u2013992. https:\/\/doi.org\/10.1101\/PDB.PROT5648","journal-title":"Cold Spring Harb Protoc"},{"key":"3402_CR105","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1084\/JEM.193.4.509","volume":"193","author":"E Jacotot","year":"2001","unstructured":"Jacotot E, Ferri KF, El Hamel C et al (2001) Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein R and Bcl-2. J Exp Med 193:509. https:\/\/doi.org\/10.1084\/JEM.193.4.509","journal-title":"J Exp Med"},{"key":"3402_CR106","doi-asserted-by":"publisher","unstructured":"Schneider A, Kurz S, Manske K et al (2019) Single organelle analysis to characterize mitochondrial function and crosstalk during viral infection. Sci Rep 9(1):1\u201311. https:\/\/doi.org\/10.1038\/S41598-019-44922-9","DOI":"10.1038\/S41598-019-44922-9"},{"key":"3402_CR107","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/CBIC.201100365","volume":"12","author":"S Lee","year":"2011","unstructured":"Lee S, Chen X (2011) Selective imaging of mitochondrial surfaces with novel fluorescent probes. ChemBioChem 12:2120. https:\/\/doi.org\/10.1002\/CBIC.201100365","journal-title":"ChemBioChem"},{"key":"3402_CR108","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/CYTO.A.21061","volume":"79A","author":"C Cottet-Rousselle","year":"2011","unstructured":"Cottet-Rousselle C, Ronot X, Leverve X, Mayol JF (2011) Cytometric assessment of mitochondria using fluorescent probes. Cytom Part A 79A:405\u2013425. https:\/\/doi.org\/10.1002\/CYTO.A.21061","journal-title":"Cytom Part A"},{"key":"3402_CR109","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/J.THERIOGENOLOGY.2004.10.010","volume":"63","author":"T Hallap","year":"2005","unstructured":"Hallap T, Nagy S, Jaakma \u00dc et al (2005) Mitochondrial activity of frozen-thawed spermatozoa assessed by MitoTracker Deep Red 633. Theriogenology 63:2311\u20132322. https:\/\/doi.org\/10.1016\/J.THERIOGENOLOGY.2004.10.010","journal-title":"Theriogenology"},{"key":"3402_CR110","doi-asserted-by":"publisher","unstructured":"Qin Y, Jiang W, Li A et al (2021) The combination of paraformaldehyde and glutaraldehyde is a potential fixative for mitochondria. Biomolecules 11(5):711. https:\/\/doi.org\/10.3390\/BIOM11050711\/S1","DOI":"10.3390\/BIOM11050711\/S1"},{"key":"3402_CR111","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.YMETH.2017.11.015","volume":"134\u2013135","author":"N Gautam","year":"2018","unstructured":"Gautam N, Sankaran S, Yason JA et al (2018) A high content imaging flow cytometry approach to study mitochondria in T cells: MitoTracker Green FM dye concentration optimization. Methods 134\u2013135:11\u201319. https:\/\/doi.org\/10.1016\/J.YMETH.2017.11.015","journal-title":"Methods"},{"key":"3402_CR112","doi-asserted-by":"publisher","first-page":"152598","DOI":"10.1016\/J.TOX.2020.152598","volume":"445","author":"E Soliman","year":"2020","unstructured":"Soliman E, Elhassanny AEM, Malur A et al (2020) Impaired mitochondrial function of alveolar macrophages in carbon nanotube-induced chronic pulmonary granulomatous disease. Toxicology 445:152598. https:\/\/doi.org\/10.1016\/J.TOX.2020.152598","journal-title":"Toxicology"},{"key":"3402_CR113","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/SHK.0B013E318292300D","volume":"39","author":"A Kholmukhamedov","year":"2013","unstructured":"Kholmukhamedov A, Schwartz JM, Lemasters JJ (2013) MitoTracker probes and mitochondrial membrane potential. Shock 39:543. https:\/\/doi.org\/10.1097\/SHK.0B013E318292300D","journal-title":"Shock"},{"key":"3402_CR114","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1016\/J.BBAGEN.2013.07.001","volume":"1830","author":"J Han","year":"2013","unstructured":"Han J, Han MS, Tung CH (2013) A non-toxic fluorogenic dye for mitochondria labeling. Biochim Biophys Acta 1830:5130. https:\/\/doi.org\/10.1016\/J.BBAGEN.2013.07.001","journal-title":"Biochim Biophys Acta"},{"key":"3402_CR115","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1570-0232(03)00371-4","volume":"793","author":"AD Presley","year":"2003","unstructured":"Presley AD, Fuller KM, Arriaga EA (2003) MitoTracker Green labeling of mitochondrial proteins and their subsequent analysis by capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr B Anal Technol Biomed Life Sci 793:141\u2013150. https:\/\/doi.org\/10.1016\/S1570-0232(03)00371-4","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"3402_CR116","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/S10517-014-2637-3","volume":"157","author":"SV Buravkov","year":"2014","unstructured":"Buravkov SV, Pogodina MV, Buravkova LB (2014) Comparison of mitochondrial fluorescent dyes in stromal cells. Bull Exp Biol Med 157:654\u2013658. https:\/\/doi.org\/10.1007\/S10517-014-2637-3","journal-title":"Bull Exp Biol Med"},{"key":"3402_CR117","doi-asserted-by":"publisher","unstructured":"Minamikawa T, Sriratana A, Williams DA et al (1999) Chloromethyl-X-rosamine (MitoTracker Red) photosensitises mitochondria and induces apoptosis in intact human cells. J Cell Sci 112 (14):2419\u20132430. https:\/\/doi.org\/10.1242\/JCS.112.14.2419","DOI":"10.1242\/JCS.112.14.2419"},{"key":"3402_CR118","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0165-0270(00)00340-X","volume":"104","author":"JF Buckman","year":"2001","unstructured":"Buckman JF, Hern\u00e1ndez H, Kress GJ et al (2001) MitoTracker labeling in primary neuronal and astrocytic cultures: influence of mitochondrial membrane potential and oxidants. J Neurosci Methods 104:165\u2013176. https:\/\/doi.org\/10.1016\/S0165-0270(00)00340-X","journal-title":"J Neurosci Methods"},{"key":"3402_CR119","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0193-953X(03)00106-0","volume":"27","author":"CL Marvel","year":"2004","unstructured":"Marvel CL, Paradiso S (2004) Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am 27:19. https:\/\/doi.org\/10.1016\/S0193-953X(03)00106-0","journal-title":"Psychiatr Clin North Am"},{"key":"3402_CR120","doi-asserted-by":"publisher","first-page":"63","DOI":"10.31887\/DCNS.2018.20.1\/BPENNINX","volume":"20","author":"BWJH Penninx","year":"2018","unstructured":"Penninx BWJH, Lange SMM (2018) Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci 20:63. https:\/\/doi.org\/10.31887\/DCNS.2018.20.1\/BPENNINX","journal-title":"Dialogues Clin Neurosci"},{"key":"3402_CR121","first-page":"638","volume":"39","author":"KR Patel","year":"2014","unstructured":"Patel KR, Cherian J, Gohil K, Atkinson D (2014) Schizophrenia: overview and treatment options. Pharm Ther 39:638","journal-title":"Pharm Ther"},{"key":"3402_CR122","doi-asserted-by":"publisher","unstructured":"Murphy D (2011) Conceptual foundations of biological psychiatry. Philos Med 16:425\u2013451. https:\/\/doi.org\/10.1016\/B978-0-444-51787-6.50013-1","DOI":"10.1016\/B978-0-444-51787-6.50013-1"},{"key":"3402_CR123","doi-asserted-by":"publisher","first-page":"53","DOI":"10.31887\/DCNS.2019.21.1\/RPERNECZKY2","volume":"21","author":"R Perneczky","year":"2019","unstructured":"Perneczky R (2019) Dementia prevention and reserve against neurodegenerative disease. Dialogues Clin Neurosci 21:53. https:\/\/doi.org\/10.31887\/DCNS.2019.21.1\/RPERNECZKY2","journal-title":"Dialogues Clin Neurosci"},{"key":"3402_CR124","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.2147\/NDT.S172933","volume":"14","author":"L Cai","year":"2018","unstructured":"Cai L, Huang J (2018) Schizophrenia and risk of dementia: a meta-analysis study. Neuropsychiatr Dis Treat 14:2047. https:\/\/doi.org\/10.2147\/NDT.S172933","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3402_CR125","doi-asserted-by":"publisher","unstructured":"Perkovic MN, Erjavec GN, Strac DS et al (2017) Theranostic biomarkers for schizophrenia. Int J Mol Sci 18(4):733. https:\/\/doi.org\/10.3390\/IJMS18040733","DOI":"10.3390\/IJMS18040733"},{"key":"3402_CR126","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/MP.2013.174","volume":"20","author":"A Merenlender-Wagner","year":"2015","unstructured":"Merenlender-Wagner A, Malishkevich A, Shemer Z et al (2015) Autophagy has a key role in the pathophysiology of schizophrenia. Mol Psychiatry 20:126. https:\/\/doi.org\/10.1038\/MP.2013.174","journal-title":"Mol Psychiatry"},{"key":"3402_CR127","doi-asserted-by":"publisher","unstructured":"Grossman M, Irwin DJ (2016) The mental status examination in patients with suspected dementia. Contin Lifelong Learn Neurol 22(2):385\u2013403. https:\/\/doi.org\/10.1212\/CON.0000000000000298","DOI":"10.1212\/CON.0000000000000298"},{"key":"3402_CR128","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/BMJ.39148.668160.80","volume":"334","author":"P Byrne","year":"2007","unstructured":"Byrne P (2007) Managing the acute psychotic episode. BMJ Br Med J 334:686. https:\/\/doi.org\/10.1136\/BMJ.39148.668160.80","journal-title":"BMJ Br Med J"},{"key":"3402_CR129","doi-asserted-by":"publisher","first-page":"271","DOI":"10.31887\/DCNS.2008.10.3\/SHKENNEDY","volume":"10","author":"SH Kennedy","year":"2008","unstructured":"Kennedy SH (2008) Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues Clin Neurosci 10:271. https:\/\/doi.org\/10.31887\/DCNS.2008.10.3\/SHKENNEDY","journal-title":"Dialogues Clin Neurosci"},{"key":"3402_CR130","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/J.BBADIS.2014.05.005","volume":"1852","author":"Y Mei","year":"2015","unstructured":"Mei Y, Thompson MD, Cohen RA, Tong XY (2015) Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta 1852:243. https:\/\/doi.org\/10.1016\/J.BBADIS.2014.05.005","journal-title":"Biochim Biophys Acta"},{"key":"3402_CR131","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/J.NEURON.2022.01.017","volume":"110","author":"A Fleming","year":"2022","unstructured":"Fleming A, Bourdenx M, Fujimaki M et al (2022) The different autophagy degradation pathways and neurodegeneration. Neuron 110:935\u2013966. https:\/\/doi.org\/10.1016\/J.NEURON.2022.01.017","journal-title":"Neuron"},{"key":"3402_CR132","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/PNAS.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham A, Rodenhiser J, Printz D et al (2000) Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 97:8104\u20138109. https:\/\/doi.org\/10.1073\/PNAS.97.14.8104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3402_CR133","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/2045125314557797","volume":"5","author":"H Steeds","year":"2015","unstructured":"Steeds H, Carhart-Harris RL, Stone JM (2015) Drug models of schizophrenia. Ther Adv Psychopharmacol 5:43. https:\/\/doi.org\/10.1177\/2045125314557797","journal-title":"Ther Adv Psychopharmacol"},{"key":"3402_CR134","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/S00702-014-1180-8","volume":"121","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Danbolt NC (2014) Glutamate as a neurotransmitter in the healthy brain. J Neural Transm 121:799. https:\/\/doi.org\/10.1007\/S00702-014-1180-8","journal-title":"J Neural Transm"},{"key":"3402_CR135","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/WPS.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Krystal JH, Howes OD (2020) Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry 19:15. https:\/\/doi.org\/10.1002\/WPS.20693","journal-title":"World Psychiatry"},{"key":"3402_CR136","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1113\/JP274330","volume":"596","author":"D Tropea","year":"2018","unstructured":"Tropea D, Hardingham N, Millar K, Fox K (2018) Mechanisms underlying the role of DISC1 in synaptic plasticity. J Physiol 596:2747. https:\/\/doi.org\/10.1113\/JP274330","journal-title":"J Physiol"},{"key":"3402_CR137","doi-asserted-by":"publisher","first-page":"111324","DOI":"10.1016\/J.CELREP.2022.111324","volume":"40","author":"H Quintero","year":"2022","unstructured":"Quintero H, Shiga Y, Belforte N et al (2022) Restoration of mitochondria axonal transport by adaptor Disc1 supplementation prevents neurodegeneration and rescues visual function. Cell Rep. 40:111324. https:\/\/doi.org\/10.1016\/J.CELREP.2022.111324","journal-title":"Cell Rep."},{"key":"3402_CR138","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/CR.2017.23","volume":"27","author":"V Lahiri","year":"2017","unstructured":"Lahiri V, Klionsky DJ (2017) PHB2\/prohibitin 2: an inner membrane mitophagy receptor. Cell Res 27:311\u2013312. https:\/\/doi.org\/10.1038\/CR.2017.23","journal-title":"Cell Res"},{"key":"3402_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11515-012-1254-7","volume":"8","author":"PA Thomson","year":"2013","unstructured":"Thomson PA, Malavasi ELV, Gr\u00fcnewald E et al (2013) DISC1 genetics, biology and psychiatric illness. Front Biol (Beijing) 8:1. https:\/\/doi.org\/10.1007\/S11515-012-1254-7","journal-title":"Front Biol (Beijing)"},{"key":"3402_CR140","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/J.SCHRES.2017.05.003","volume":"187","author":"KH Flippo","year":"2017","unstructured":"Flippo KH, Strack S (2017) An emerging role for mitochondrial dynamics in schizophrenia. Schizophr Res 187:26. https:\/\/doi.org\/10.1016\/J.SCHRES.2017.05.003","journal-title":"Schizophr Res"},{"key":"3402_CR141","doi-asserted-by":"publisher","unstructured":"Baldessarini RJ, V\u00e1zquez GH, Tondo L (2020) Bipolar depression: a major unsolved challenge. Int J Bipolar Disord 8(1):1. https:\/\/doi.org\/10.1186\/S40345-019-0160-1","DOI":"10.1186\/S40345-019-0160-1"},{"key":"3402_CR142","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2353\/AJPATH.2010.081068","volume":"177","author":"AM Cataldo","year":"2010","unstructured":"Cataldo AM, McPhie DL, Lange NT et al (2010) Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol 177:575\u2013585. https:\/\/doi.org\/10.2353\/AJPATH.2010.081068","journal-title":"Am J Pathol"},{"key":"3402_CR143","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/J.BBADIS.2009.04.003","volume":"1792","author":"F Reinecke","year":"2009","unstructured":"Reinecke F, Smeitink JAM, van der Westhuizen FH (2009) OXPHOS gene expression and control in mitochondrial disorders. Biochim Biophys Acta - Mol Basis Dis 1792:1113\u20131121. https:\/\/doi.org\/10.1016\/J.BBADIS.2009.04.003","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"3402_CR144","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.SCHRES.2017.01.056","volume":"187","author":"RC Roberts","year":"2017","unstructured":"Roberts RC (2017) Postmortem studies on mitochondria in schizophrenia. Schizophr Res 187:17. https:\/\/doi.org\/10.1016\/J.SCHRES.2017.01.056","journal-title":"Schizophr Res"},{"key":"3402_CR145","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3969\/J.ISSN.1673-5374.2013.21.009","volume":"8","author":"CY Guo","year":"2013","unstructured":"Guo CY, Sun L, Chen XP, Zhang DS (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8:2003. https:\/\/doi.org\/10.3969\/J.ISSN.1673-5374.2013.21.009","journal-title":"Neural Regen Res"},{"key":"3402_CR146","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1111\/JCMM.16763","volume":"25","author":"J Liu","year":"2021","unstructured":"Liu J, Liu L, Han YS et al (2021) The molecular mechanism underlying mitophagy-mediated hippocampal neuron apoptosis in diabetes-related depression. J Cell Mol Med 25:7342\u20137353. https:\/\/doi.org\/10.1111\/JCMM.16763","journal-title":"J Cell Mol Med"},{"key":"3402_CR147","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/S41386-018-0293-4","volume":"44","author":"G Scaini","year":"2019","unstructured":"Scaini G, Barichello T, Fries GR et al (2019) TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation. Neuropsychopharmacology 44:1291. https:\/\/doi.org\/10.1038\/S41386-018-0293-4","journal-title":"Neuropsychopharmacology"},{"key":"3402_CR148","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.4161\/15548627.2014.991665","volume":"10","author":"J Gatliff","year":"2014","unstructured":"Gatliff J, East D, Crosby J et al (2014) TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control. Autophagy 10:2279. https:\/\/doi.org\/10.4161\/15548627.2014.991665","journal-title":"Autophagy"},{"key":"3402_CR149","first-page":"73","volume":"3","author":"MT Tsuang","year":"2004","unstructured":"Tsuang MT, Bar JL, Stone WS, Faraone SV (2004) Gene-environment interactions in mental disorders. World Psychiatry 3:73","journal-title":"World Psychiatry"},{"key":"3402_CR150","doi-asserted-by":"publisher","unstructured":"Ogundele MO (2018) Behavioural and emotional disorders in childhood: a brief overview for paediatricians. World J Clin Pediatr 7(1):9. https:\/\/doi.org\/10.5409\/WJCP.V7.I1.9","DOI":"10.5409\/WJCP.V7.I1.9"},{"key":"3402_CR151","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T et al (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"key":"3402_CR152","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/FNINS.2018.00386","volume":"12","author":"J Allen","year":"2018","unstructured":"Allen J, Romay-Tallon R, Brymer KJ et al (2018) Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression. Front Neurosci 12:386. https:\/\/doi.org\/10.3389\/FNINS.2018.00386","journal-title":"Front Neurosci"},{"key":"3402_CR153","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/J.SCHRES.2019.09.007","volume":"217","author":"ST Chan","year":"2020","unstructured":"Chan ST, McCarthy MJ, Vawter MP (2020) Psychiatric drugs impact mitochondrial function in brain and other tissues. Schizophr Res 217:136\u2013147. https:\/\/doi.org\/10.1016\/J.SCHRES.2019.09.007","journal-title":"Schizophr Res"},{"key":"3402_CR154","doi-asserted-by":"publisher","first-page":"104469","DOI":"10.1016\/J.NEUINT.2019.104469","volume":"129","author":"S Lautrup","year":"2019","unstructured":"Lautrup S, Lou G, Aman Y et al (2019) Microglial mitophagy mitigates neuroinflammation in Alzheimer\u2019s disease. Neurochem Int 129:104469. https:\/\/doi.org\/10.1016\/J.NEUINT.2019.104469","journal-title":"Neurochem Int"},{"key":"3402_CR155","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1080\/15548627.2016.1170257","volume":"12","author":"A Goode","year":"2016","unstructured":"Goode A, Butler K, Long J et al (2016) Defective recognition of LC3B by mutant SQSTM1\/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Autophagy 12:1094. https:\/\/doi.org\/10.1080\/15548627.2016.1170257","journal-title":"Autophagy"},{"key":"3402_CR156","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-6890-9_13","volume":"123","author":"RK Dagda","year":"2017","unstructured":"Dagda RK, Rice M (2017) Protocols for assessing mitophagy in neuronal cell lines and primary neurons. NeuroMethods 123:249. https:\/\/doi.org\/10.1007\/978-1-4939-6890-9_13","journal-title":"NeuroMethods"},{"key":"3402_CR157","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/BRAIN\/AWV371","volume":"139","author":"D Ebrahimi-Fakhari","year":"2016","unstructured":"Ebrahimi-Fakhari D, Saffari A, Wahlster L et al (2016) Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism. Brain 139:317. https:\/\/doi.org\/10.1093\/BRAIN\/AWV371","journal-title":"Brain"},{"key":"3402_CR158","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.4103\/0975-7406.137249","volume":"6","author":"S Jeelani","year":"2014","unstructured":"Jeelani S, Jagat Reddy RC, Maheswaran T et al (2014) Theranostics: a treasured tailor for tomorrow. J Pharm Bioallied Sci 6:S6. https:\/\/doi.org\/10.4103\/0975-7406.137249","journal-title":"J Pharm Bioallied Sci"},{"key":"3402_CR159","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/2472630317738699","volume":"23","author":"C Zavaleta","year":"2018","unstructured":"Zavaleta C, Ho D, Chung EJ (2018) Theranostic nanoparticles for tracking and monitoring disease state. SLAS Technol 23:281. https:\/\/doi.org\/10.1177\/2472630317738699","journal-title":"SLAS Technol"},{"issue":"49","key":"3402_CR160","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1007\/S00259-022-05894-7","volume":"4913","author":"P Cen","year":"2022","unstructured":"Cen P, Zhou Y, Cui C et al (2022) Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens. Eur J Nucl Med Mol Imaging 4913(49):4529\u20134550. https:\/\/doi.org\/10.1007\/S00259-022-05894-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"16","key":"3402_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12951-018-0392-8","volume":"161","author":"JK Patra","year":"2018","unstructured":"Patra JK, Das G, Fraceto LF et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 161(16):1\u201333. https:\/\/doi.org\/10.1186\/S12951-018-0392-8","journal-title":"J Nanobiotechnology"},{"key":"3402_CR162","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1208\/S12248-015-9814-9","volume":"17","author":"H Wen","year":"2015","unstructured":"Wen H, Jung H, Li X (2015) Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. AAPS J 17:1327. https:\/\/doi.org\/10.1208\/S12248-015-9814-9","journal-title":"AAPS J"},{"key":"3402_CR163","first-page":"129","volume":"2","author":"SK Murthy","year":"2007","unstructured":"Murthy SK (2007) Nanoparticles in modern medicine: state of the art and future challenges. Int J Nanomedicine 2:129","journal-title":"Int J Nanomedicine"},{"key":"3402_CR164","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1016\/J.ARABJC.2015.11.002","volume":"12","author":"D Sharma","year":"2019","unstructured":"Sharma D, Kanchi S, Bisetty K (2019) Biogenic synthesis of nanoparticles: a review. Arab J Chem 12:3576\u20133600. https:\/\/doi.org\/10.1016\/J.ARABJC.2015.11.002","journal-title":"Arab J Chem"},{"key":"3402_CR165","doi-asserted-by":"publisher","unstructured":"Madamsetty VS, Mukherjee A, Mukherjee S (2019) Recent trends of the bio-inspired nanoparticles in cancer theranostics. Front Pharmacol 10:1264. https:\/\/doi.org\/10.3389\/FPHAR.2019.01264","DOI":"10.3389\/FPHAR.2019.01264"},{"key":"3402_CR166","doi-asserted-by":"publisher","first-page":"1900102","DOI":"10.1002\/ADTP.201900102","volume":"3","author":"W Yang","year":"2020","unstructured":"Yang W, Veroniaina H, Qi X et al (2020) Soft and condensed nanoparticles and nanoformulations for cancer drug delivery and repurpose. Adv Ther 3:1900102. https:\/\/doi.org\/10.1002\/ADTP.201900102","journal-title":"Adv Ther"},{"key":"3402_CR167","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/J.AJPS.2020.03.003","volume":"16","author":"PI Siafaka","year":"2021","unstructured":"Siafaka PI, Okur N\u00dc, Karantas ID et al (2021) Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities. Asian J Pharm Sci 16:24\u201346. https:\/\/doi.org\/10.1016\/J.AJPS.2020.03.003","journal-title":"Asian J Pharm Sci"},{"key":"3402_CR168","doi-asserted-by":"publisher","unstructured":"Gaur M, Misra C, Yadav AB et al (2021) Biomedical applications of carbon nanomaterials: Fullerenes, quantum dots, nanotubes, nanofibers, and graphene. Materials (Basel) 14(20):1\u201335. https:\/\/doi.org\/10.3390\/MA14205978","DOI":"10.3390\/MA14205978"},{"key":"3402_CR169","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1039\/C3NR02694A","volume":"5","author":"A Battigelli","year":"2013","unstructured":"Battigelli A, Russier J, Venturelli E et al (2013) Peptide-based carbon nanotubes for mitochondrial targeting. Nanoscale 5:9110\u20139117. https:\/\/doi.org\/10.1039\/C3NR02694A","journal-title":"Nanoscale"},{"key":"3402_CR170","doi-asserted-by":"publisher","first-page":"106041","DOI":"10.1016\/J.CLAY.2021.106041","volume":"205","author":"E Rozhina","year":"2021","unstructured":"Rozhina E, Batasheva S, Miftakhova R et al (2021) Comparative cytotoxicity of kaolinite, halloysite, multiwalled carbon nanotubes and graphene oxide. Appl Clay Sci 205:106041. https:\/\/doi.org\/10.1016\/J.CLAY.2021.106041","journal-title":"Appl Clay Sci"},{"key":"3402_CR171","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/978-1-4939-2425-7_34","volume":"1278","author":"T Miyashita","year":"2015","unstructured":"Miyashita T (2015) Confocal microscopy for intracellular co-localization of proteins. Methods Mol Biol 1278:515\u2013526. https:\/\/doi.org\/10.1007\/978-1-4939-2425-7_34","journal-title":"Methods Mol Biol"},{"key":"3402_CR172","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/B978-0-444-63964-6.00009-X","volume":"42","author":"DR Esfahani","year":"2018","unstructured":"Esfahani DR, Tangen KM, Sadeh M et al (2018) Systems engineers\u2019 role in biomedical research. Convection-enhanced drug delivery. Comput Aided Chem Eng 42:271\u2013302. https:\/\/doi.org\/10.1016\/B978-0-444-63964-6.00009-X","journal-title":"Comput Aided Chem Eng"},{"key":"3402_CR173","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/J.JCONREL.2012.01.009","volume":"159","author":"S Biswas","year":"2012","unstructured":"Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP (2012) Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release 159:393. https:\/\/doi.org\/10.1016\/J.JCONREL.2012.01.009","journal-title":"J Control Release"},{"key":"3402_CR174","doi-asserted-by":"publisher","unstructured":"Chen T, Chen H, Jiang Y et al (2022) Co-Delivery of 5-Fluorouracil and Paclitaxel in mitochondria-targeted KLA-modified liposomes to improve triple-negative breast cancer treatment. Pharm 15(7):881. https:\/\/doi.org\/10.3390\/PH15070881","DOI":"10.3390\/PH15070881"},{"key":"3402_CR175","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1176\/APPI.AJP.159.2.180","volume":"159","author":"S Leucht","year":"2002","unstructured":"Leucht S, Pitschel-Walz G, Engel RR, Kissling W (2002) Amisulpride, an unusual \u201catypical\u201d antipsychotic: a meta-analysis of randomized controlled trials. Am J Psychiatry 159:180\u2013190. https:\/\/doi.org\/10.1176\/APPI.AJP.159.2.180","journal-title":"Am J Psychiatry"},{"key":"3402_CR176","doi-asserted-by":"publisher","unstructured":"Zielinska A, Carreir\u00f3 F, Oliveira AM et al (2020) Polymeric nanoparticles: Production, characterization, toxicology and ecotoxicology. Molecules 25(16):3731. https:\/\/doi.org\/10.3390\/MOLECULES25163731","DOI":"10.3390\/MOLECULES25163731"},{"key":"3402_CR177","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.CHROMA.2016.10.006","volume":"1470","author":"D Fan","year":"2016","unstructured":"Fan D, Li H, Shi S, Chen X (2016) Hollow molecular imprinted polymers towards rapid, effective and selective extraction of caffeic acid from fruits. J Chromatogr A 1470:27\u201332. https:\/\/doi.org\/10.1016\/J.CHROMA.2016.10.006","journal-title":"J Chromatogr A"},{"key":"3402_CR178","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/ANNUREV-CHEMBIOENG-073009-100847","volume":"1","author":"WB Liechty","year":"2010","unstructured":"Liechty WB, Kryscio DR, Slaughter BV, Peppas NA (2010) Polymers for drug delivery systems. Annu Rev Chem Biomol Eng 1:149. https:\/\/doi.org\/10.1146\/ANNUREV-CHEMBIOENG-073009-100847","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"3402_CR179","doi-asserted-by":"publisher","unstructured":"Makadia HK, Siegel SJ (2011) Poly Lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polym 3(3):1377\u20131397. https:\/\/doi.org\/10.3390\/POLYM3031377","DOI":"10.3390\/POLYM3031377"},{"key":"3402_CR180","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1080\/03639045.2019.1619759","volume":"45","author":"R Rukmangathen","year":"2019","unstructured":"Rukmangathen R, Yallamalli IM, Yalavarthi PR (2019) Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Drug Dev Ind Pharm 45:1342\u20131350. https:\/\/doi.org\/10.1080\/03639045.2019.1619759","journal-title":"Drug Dev Ind Pharm"},{"key":"3402_CR181","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/10837450.2014.965324","volume":"21","author":"A Panda","year":"2016","unstructured":"Panda A, Meena J, Katara R, Majumdar DK (2016) Formulation and characterization of clozapine and risperidone co-entrapped spray-dried PLGA nanoparticles. Pharm Dev Technol 21:43\u201353. https:\/\/doi.org\/10.3109\/10837450.2014.965324","journal-title":"Pharm Dev Technol"},{"key":"3402_CR182","doi-asserted-by":"publisher","unstructured":"Coupland JN, Hayes JE (2014) Physical Approaches to masking bitter taste: Lessons from food and pharmaceuticals. Pharm Res 31(11):2921. https:\/\/doi.org\/10.1007\/S11095-014-1480-6","DOI":"10.1007\/S11095-014-1480-6"},{"key":"3402_CR183","doi-asserted-by":"crossref","unstructured":"Komossa K, Rummel-Kluge C, Schmid F et al (2009) Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane database Syst Rev 2(4):CD006569","DOI":"10.1002\/14651858.CD006569.pub3"},{"key":"3402_CR184","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.2147\/IJN.S89364","volume":"10","author":"HRF Masoumi","year":"2015","unstructured":"Masoumi HRF, Basri M, Samiun WS et al (2015) Enhancement of encapsulation efficiency of nanoemulsion-containing aripiprazole for the treatment of schizophrenia using mixture experimental design. Int J Nanomedicine 10:6469\u20136476. https:\/\/doi.org\/10.2147\/IJN.S89364","journal-title":"Int J Nanomedicine"},{"key":"3402_CR185","doi-asserted-by":"publisher","unstructured":"Aderibigbe BA, Naki T (2018) Design and efficacy of nanogels formulations for intranasal administration. Mol  A J Synth Chem Nat Prod Chem 23(6):1241. https:\/\/doi.org\/10.3390\/MOLECULES23061241","DOI":"10.3390\/MOLECULES23061241"},{"key":"3402_CR186","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/J.JCONREL.2015.11.009","volume":"240","author":"KS Soni","year":"2016","unstructured":"Soni KS, Desale SS, Bronich TK (2016) Nanogels: an overview of properties, biomedical applications and obstacles to clinical translation. J Control Release 240:109. https:\/\/doi.org\/10.1016\/J.JCONREL.2015.11.009","journal-title":"J Control Release"},{"key":"3402_CR187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/S12249-020-01694-0\/METRICS","volume":"21","author":"KU Khan","year":"2020","unstructured":"Khan KU, Akhtar N, Minhas MU (2020) Poloxamer-407-co-poly (2-acrylamido-2-methylpropane sulfonic acid) cross-linked nanogels for solubility enhancement of olanzapine: synthesis, characterization, and toxicity evaluation. AAPS PharmSciTech 21:1\u201315. https:\/\/doi.org\/10.1208\/S12249-020-01694-0\/METRICS","journal-title":"AAPS PharmSciTech"},{"key":"3402_CR188","doi-asserted-by":"publisher","unstructured":"Daneman R, Prat A (2015) The blood\u2013brain barrier. Cold Spring Harb Perspect Biol 7(1):a020412. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A020412","DOI":"10.1101\/CSHPERSPECT.A020412"},{"key":"3402_CR189","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/JCBFM.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM (2012) Drug transport across the blood\u2013brain barrier. J Cereb Blood Flow Metab 32:1959. https:\/\/doi.org\/10.1038\/JCBFM.2012.126","journal-title":"J Cereb Blood Flow Metab"},{"key":"3402_CR190","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/J.CONB.2018.12.014","volume":"57","author":"S Ayloo","year":"2019","unstructured":"Ayloo S, Gu C (2019) Transcytosis at the blood-brain barrier. Curr Opin Neurobiol 57:32. https:\/\/doi.org\/10.1016\/J.CONB.2018.12.014","journal-title":"Curr Opin Neurobiol"},{"key":"3402_CR191","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/S12951-022-01251-W","volume":"20","author":"W Lei","year":"2022","unstructured":"Lei W, Yang C, Wu Y et al (2022) Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy. J Nanobiotechnology 20:45. https:\/\/doi.org\/10.1186\/S12951-022-01251-W","journal-title":"J Nanobiotechnology"},{"key":"3402_CR192","doi-asserted-by":"publisher","unstructured":"He Q, Liu J, Liang J et al (2018) Towards improvements for penetrating the blood\u2013brain barrier\u2014recent progress from a material and pharmaceutical perspective. Cells 7(4):24. https:\/\/doi.org\/10.3390\/CELLS7040024","DOI":"10.3390\/CELLS7040024"},{"key":"3402_CR193","doi-asserted-by":"publisher","first-page":"225","DOI":"10.15171\/BI.2016.30","volume":"6","author":"J Barar","year":"2016","unstructured":"Barar J, Rafi MA, Pourseif MM, Omidi Y (2016) Blood-brain barrier transport machineries and targeted therapy of brain diseases. Bioimpacts 6:225. https:\/\/doi.org\/10.15171\/BI.2016.30","journal-title":"Bioimpacts"},{"key":"3402_CR194","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000069852","volume":"98","author":"C Prades","year":"2002","unstructured":"Prades C, Arnould I, Annilo T et al (2002) The human ATP binding cassette gene ABCA13, located on chromosome 7p12.3, encodes a 5058 amino acid protein with an extracellular domain encoded in part by a 4.8-kb conserved exon. Cytogenet Genome Res 98:160\u2013168. https:\/\/doi.org\/10.1159\/000069852","journal-title":"Cytogenet Genome Res"},{"key":"3402_CR195","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/CPT.64","volume":"97","author":"DS Miller","year":"2015","unstructured":"Miller DS (2015) Regulation of ABC transporters at the blood-brain barrier. Clin Pharmacol Ther 97:395. https:\/\/doi.org\/10.1002\/CPT.64","journal-title":"Clin Pharmacol Ther"},{"key":"3402_CR196","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/J.AJHG.2009.11.003","volume":"85","author":"HM Knight","year":"2009","unstructured":"Knight HM, Pickard BS, Maclean A et al (2009) A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression. Am J Hum Genet 85:833\u2013846. https:\/\/doi.org\/10.1016\/J.AJHG.2009.11.003","journal-title":"Am J Hum Genet"},{"key":"3402_CR197","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1271\/BBB.120563","volume":"76","author":"M Tomioka","year":"2012","unstructured":"Tomioka M, Toda Y, Kurisu J et al (2012) The effects of neurological disorder-related codon variations of ABCA13 on the function of the ABC protein. Biosci Biotechnol Biochem 76:2289\u20132293. https:\/\/doi.org\/10.1271\/BBB.120563","journal-title":"Biosci Biotechnol Biochem"},{"key":"3402_CR198","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/15622975.2016.1245442","volume":"18","author":"J Chen","year":"2017","unstructured":"Chen J, Khan RAW, Wang M et al (2017) Association between the variability of the ABCA13 gene and the risk of major depressive disorder and schizophrenia in the Han Chinese population. World J Biol Psychiatry 18:550\u2013556. https:\/\/doi.org\/10.1080\/15622975.2016.1245442","journal-title":"World J Biol Psychiatry"},{"issue":"10","key":"3402_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78530-9","volume":"101","author":"L Qian","year":"2020","unstructured":"Qian L, Qin Y, Chen X et al (2020) ATP-binding cassette transporter 13 mRNA expression level in schizophrenia patients. Sci Reports 101(10):1\u20135. https:\/\/doi.org\/10.1038\/s41598-020-78530-9","journal-title":"Sci Reports"},{"key":"3402_CR200","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/S00424-020-02441-X","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H (2020) Glucose transporters in brain in health and disease. Pflugers Arch 472:1299. https:\/\/doi.org\/10.1007\/S00424-020-02441-X","journal-title":"Pflugers Arch"},{"key":"3402_CR201","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/GLIA.440140107","volume":"14","author":"S Morgello","year":"1995","unstructured":"Morgello S, Uson RR, Schwartz EJ, Haber RS (1995) The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Glia 14:43\u201354. https:\/\/doi.org\/10.1002\/GLIA.440140107","journal-title":"Glia"},{"key":"3402_CR202","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/BIOM10030384","volume":"10","author":"A Bryll","year":"2020","unstructured":"Bryll A, Skrzypek J, Krzy\u015bciak W et al (2020) Oxidative-antioxidant imbalance and impaired glucose metabolism in schizophrenia. Biomolecules 10:384. https:\/\/doi.org\/10.3390\/BIOM10030384","journal-title":"Biomolecules"},{"key":"3402_CR203","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2217\/BMM.09.30","volume":"3","author":"MB Maas","year":"2009","unstructured":"Maas MB, Furie KL (2009) Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med 3:363. https:\/\/doi.org\/10.2217\/BMM.09.30","journal-title":"Biomark Med"},{"key":"3402_CR204","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/MP.2017.156","volume":"23","author":"C Greene","year":"2018","unstructured":"Greene C, Kealy J, Humphries MM et al (2018) Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. Mol Psychiatry 23:2156. https:\/\/doi.org\/10.1038\/MP.2017.156","journal-title":"Mol Psychiatry"},{"key":"3402_CR205","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3760\/cma.j.issn.1006-7876.2020.02.012","volume":"53","author":"M Yu","year":"2018","unstructured":"Yu M, Sun N, Buajieerguli M et al (2018) Glucose transporter type 1 deficiency syndrome. Chinese J Neurol 53:138\u2013142. https:\/\/doi.org\/10.3760\/cma.j.issn.1006-7876.2020.02.012","journal-title":"Chinese J Neurol"},{"key":"3402_CR206","doi-asserted-by":"publisher","unstructured":"Zaragoz\u00e1 R (2020) Transport of amino acids across the Blood-Brain Barrier. Front Physiol 11:973. https:\/\/doi.org\/10.3389\/FPHYS.2020.00973","DOI":"10.3389\/FPHYS.2020.00973"},{"key":"3402_CR207","doi-asserted-by":"publisher","unstructured":"Combs JA, Denicola GM (2019) The non-essential amino acid cysteine becomes essential for tumor proliferation and survival. Cancers (Basel) 11(5):678. https:\/\/doi.org\/10.3390\/CANCERS11050678","DOI":"10.3390\/CANCERS11050678"},{"key":"3402_CR208","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/S00018-012-0963-Z","volume":"69","author":"HTT Nguyen","year":"2012","unstructured":"Nguyen HTT, Merlin D (2012) Homeostatic and innate immune responses: role of the transmembrane glycoprotein CD98. Cell Mol Life Sci 69:3015. https:\/\/doi.org\/10.1007\/S00018-012-0963-Z","journal-title":"Cell Mol Life Sci"},{"key":"3402_CR209","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1523\/JNEUROSCI.15-05-03952.1995","volume":"15","author":"F Zafra","year":"1995","unstructured":"Zafra F, Aragon C, Olivares L et al (1995) Glycine transporters are differentially expressed among CNS cells. J Neurosci 15:3952\u20133969. https:\/\/doi.org\/10.1523\/JNEUROSCI.15-05-03952.1995","journal-title":"J Neurosci"},{"key":"3402_CR210","doi-asserted-by":"publisher","unstructured":"Barsch L, Werdehausen R, Leffler A, Eulenburg V (2021) Modulation of glycinergic neurotransmission may contribute to the analgesic effects of propacetamol. Biomolecules 11(4):493. https:\/\/doi.org\/10.3390\/BIOM11040493","DOI":"10.3390\/BIOM11040493"},{"key":"3402_CR211","doi-asserted-by":"publisher","first-page":"7586","DOI":"10.1523\/JNEUROSCI.23-20-07586.2003","volume":"23","author":"GG Kinney","year":"2003","unstructured":"Kinney GG, Sur C, Burno M et al (2003) The glycine transporter type 1 inhibitor N-[3-(4\u2032-fluorophenyl)-3-(4\u2032-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. J Neurosci 23:7586. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-20-07586.2003","journal-title":"J Neurosci"},{"key":"3402_CR212","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1021\/CN200108Z\/ASSET\/IMAGES\/LARGE\/CN-2011-00108Z_0001.JPEG","volume":"2","author":"CR Hopkins","year":"2011","unstructured":"Hopkins CR (2011) ACS chemical neuroscience molecule spotlight on RG1678. ACS Chem Neurosci 2:685\u2013686. https:\/\/doi.org\/10.1021\/CN200108Z\/ASSET\/IMAGES\/LARGE\/CN-2011-00108Z_0001.JPEG","journal-title":"ACS Chem Neurosci"},{"key":"3402_CR213","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2217\/PGS.11.55","volume":"12","author":"T Moons","year":"2011","unstructured":"Moons T, De Roo M, Claes S, Dom G (2011) Relationship between P-glycoprotein and second-generation antipsychotics. Pharmacogenomics 12:1193\u20131211. https:\/\/doi.org\/10.2217\/PGS.11.55","journal-title":"Pharmacogenomics"},{"key":"3402_CR214","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1208\/S12248-014-9668-6","volume":"17","author":"Q Mao","year":"2015","unstructured":"Mao Q, Unadkat JD (2015) Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport\u2014an update. AAPS J 17:65. https:\/\/doi.org\/10.1208\/S12248-014-9668-6","journal-title":"AAPS J"},{"key":"3402_CR215","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5732\/CJC.011.10329","volume":"31","author":"K Sodani","year":"2012","unstructured":"Sodani K, Patel A, Kathawala RJ, Chen ZS (2012) Multidrug resistance associated proteins in multidrug resistance. Chin J Cancer 31:58. https:\/\/doi.org\/10.5732\/CJC.011.10329","journal-title":"Chin J Cancer"},{"key":"3402_CR216","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5049\/EBP.2006.4.1.8","volume":"4","author":"WK Lee","year":"2006","unstructured":"Lee WK, Jung SM, Kwak JO, Cha SH (2006) Introduction of organic anion transporters (SLC22A) and a regulatory mechanism by caveolins. Electrolytes Blood Press E BP 4:8. https:\/\/doi.org\/10.5049\/EBP.2006.4.1.8","journal-title":"Electrolytes Blood Press E BP"},{"key":"3402_CR217","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/J.1476-5381.2011.01724.X","volume":"165","author":"M Roth","year":"2012","unstructured":"Roth M, Obaidat A, Hagenbuch B (2012) OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol 165:1260. https:\/\/doi.org\/10.1111\/J.1476-5381.2011.01724.X","journal-title":"Br J Pharmacol"},{"key":"3402_CR218","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/J.PHRS.2016.06.002","volume":"111","author":"DJ Wagner","year":"2016","unstructured":"Wagner DJ, Hu T, Wang J (2016) Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics. Pharmacol Res 111:237. https:\/\/doi.org\/10.1016\/J.PHRS.2016.06.002","journal-title":"Pharmacol Res"},{"key":"3402_CR219","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2174\/13816128113199990462","volume":"20","author":"N Vijay","year":"2014","unstructured":"Vijay N, Morris ME (2014) Role of monocarboxylate transporters in drug delivery to the brain. Curr Pharm Des 20:1487. https:\/\/doi.org\/10.2174\/13816128113199990462","journal-title":"Curr Pharm Des"},{"key":"3402_CR220","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1021\/JF500916D","volume":"62","author":"JH Lee","year":"2014","unstructured":"Lee JH, Lee JE, Kim Y et al (2014) Multidrug and toxic compound extrusion protein-1 (MATE1\/SLC47A1) is a novel flavonoid transporter. J Agric Food Chem 62:9690\u20139698. https:\/\/doi.org\/10.1021\/JF500916D","journal-title":"J Agric Food Chem"},{"key":"3402_CR221","doi-asserted-by":"publisher","unstructured":"Blanco-V\u00e1zquez C, Alonso-Hearn M, Iglesias N et al (2022) Use of ATP-binding cassette subfamily A member 13 (ABCA13) for sensitive detection of focal pathological forms of subclinical bovine paratuberculosis. Front Vet Sci 9:126. https:\/\/doi.org\/10.3389\/FVETS.2022.816135\/BIBTEX","DOI":"10.3389\/FVETS.2022.816135\/BIBTEX"},{"key":"3402_CR222","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4103\/JOMFP.JOMFP_22_18","volume":"23","author":"S Pragallapati","year":"2019","unstructured":"Pragallapati S, Manyam R (2019) Glucose transporter 1 in health and disease. J Oral Maxillofac Pathol 23:443. https:\/\/doi.org\/10.4103\/JOMFP.JOMFP_22_18","journal-title":"J Oral Maxillofac Pathol"},{"key":"3402_CR223","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/EMBOJ\/21.4.580","volume":"21","author":"C Meier","year":"2002","unstructured":"Meier C, Ristic Z, Klauser S, Verrey F (2002) Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J 21:580. https:\/\/doi.org\/10.1093\/EMBOJ\/21.4.580","journal-title":"EMBO J"},{"key":"3402_CR224","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1523\/JNEUROSCI.15-03-02524.1995","volume":"15","author":"RH Adams","year":"1995","unstructured":"Adams RH, Sato K, Shimada S et al (1995) Gene structure and glial expression of the glycine transporter GlyT1 in embryonic and adult rodents. J Neurosci 15:2524\u20132532. https:\/\/doi.org\/10.1523\/JNEUROSCI.15-03-02524.1995","journal-title":"J Neurosci"},{"key":"3402_CR225","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/ACSSYNBIO.1C00576\/ASSET\/IMAGES\/LARGE\/SB1C00576_0004.JPEG","volume":"11","author":"A Khan","year":"2022","unstructured":"Khan A, Ostaku J, Aras E, Safak Seker UO (2022) Combating infectious diseases with synthetic biology. ACS Synth Biol 11:528\u2013537. https:\/\/doi.org\/10.1021\/ACSSYNBIO.1C00576\/ASSET\/IMAGES\/LARGE\/SB1C00576_0004.JPEG","journal-title":"ACS Synth Biol"},{"key":"3402_CR226","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3389\/FONC.2020.01594","volume":"10","author":"U Greenbaum","year":"2020","unstructured":"Greenbaum U, Mahadeo KM, Kebriaei P et al (2020) Chimeric antigen receptor T-cells in B-acute lymphoblastic leukemia: state of the art and future directions. Front Oncol 10:1594. https:\/\/doi.org\/10.3389\/FONC.2020.01594","journal-title":"Front Oncol"},{"key":"3402_CR227","doi-asserted-by":"publisher","unstructured":"B\u0103la\u0219a AF, Chircov C, Grumezescu AM (2020) Marine biocompounds for neuroprotection\u2014a review. Mar Drugs 18(6):290. https:\/\/doi.org\/10.3390\/MD18060290","DOI":"10.3390\/MD18060290"},{"key":"3402_CR228","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/J.TAAP.2010.03.022","volume":"245","author":"S Choudhuri","year":"2010","unstructured":"Choudhuri S, Cui Y, Klaassen CD (2010) Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol Appl Pharmacol 245:378. https:\/\/doi.org\/10.1016\/J.TAAP.2010.03.022","journal-title":"Toxicol Appl Pharmacol"},{"key":"3402_CR229","doi-asserted-by":"publisher","unstructured":"Eshraghi M, Adlimoghaddam A, Mahmoodzadeh A et al (2021) Alzheimer\u2019s disease pathogenesis: role of autophagy and mitophagy focusing in microglia. Int J Mol Sci 22(7):3330. https:\/\/doi.org\/10.3390\/IJMS22073330","DOI":"10.3390\/IJMS22073330"},{"key":"3402_CR230","doi-asserted-by":"publisher","unstructured":"De Oliveira J, Kucharska E, Garcez ML et al (2021) Inflammatory cascade in Alzheimer\u2019s disease pathogenesis: a review of experimental findings. Cells 10(10):2581. https:\/\/doi.org\/10.3390\/CELLS10102581","DOI":"10.3390\/CELLS10102581"},{"key":"3402_CR231","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1002\/JCP.30152","volume":"236","author":"K Azizian","year":"2021","unstructured":"Azizian K, Pustokhina I, Ghanavati R et al (2021) The potential use of theranostic bacteria in cancer. J Cell Physiol 236:4184\u20134194. https:\/\/doi.org\/10.1002\/JCP.30152","journal-title":"J Cell Physiol"},{"key":"3402_CR232","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang L, Hu C, Shao L (2017) The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine 12:1227. https:\/\/doi.org\/10.2147\/IJN.S121956","journal-title":"Int J Nanomedicine"},{"key":"3402_CR233","doi-asserted-by":"publisher","first-page":"1801309","DOI":"10.1002\/ADVS.201801309","volume":"6","author":"SB Suh","year":"2019","unstructured":"Suh SB, Jo A, Traore MA et al (2019) Nanoscale bacteria-enabled autonomous drug delivery system (nanoBEADS) enhances intratumoral transport of nanomedicine. Adv Sci 6:1801309. https:\/\/doi.org\/10.1002\/ADVS.201801309","journal-title":"Adv Sci"},{"key":"3402_CR234","doi-asserted-by":"publisher","first-page":"8069","DOI":"10.2147\/IJN.S329855","volume":"16","author":"Z Ye","year":"2021","unstructured":"Ye Z, Liang L, Lu H et al (2021) Nanotechnology-employed bacteria-based delivery strategy for enhanced anticancer therapy. Int J Nanomedicine 16:8069. https:\/\/doi.org\/10.2147\/IJN.S329855","journal-title":"Int J Nanomedicine"},{"key":"3402_CR235","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/1061186X.2017.1419362","volume":"26","author":"S Wang","year":"2018","unstructured":"Wang S, Hossack JA, Klibanov AL (2018) Targeting of microbubbles - contrast agents for ultrasound molecular imaging. J Drug Target 26:420. https:\/\/doi.org\/10.1080\/1061186X.2017.1419362","journal-title":"J Drug Target"},{"key":"3402_CR236","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/J.JCONREL.2015.02.033","volume":"204","author":"M Aryal","year":"2015","unstructured":"Aryal M, Vykhodtseva N, Zhang YZ, McDannold N (2015) Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study. J Control Release 204:60. https:\/\/doi.org\/10.1016\/J.JCONREL.2015.02.033","journal-title":"J Control Release"},{"key":"3402_CR237","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1021\/ACS.CHEMREV.5B00346\/ASSET\/IMAGES\/ACS.CHEMREV.5B00346.SOCIAL.JPEG_V03","volume":"116","author":"N Kamaly","year":"2016","unstructured":"Kamaly N, Yameen B, Wu J, Farokhzad OC (2016) Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev 116:2602\u20132663. https:\/\/doi.org\/10.1021\/ACS.CHEMREV.5B00346\/ASSET\/IMAGES\/ACS.CHEMREV.5B00346.SOCIAL.JPEG_V03","journal-title":"Chem Rev"},{"key":"3402_CR238","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/03639045.2016.1275668","volume":"43","author":"M Karimzadeh","year":"2017","unstructured":"Karimzadeh M, Rashidi L, Ganji F (2017) Mesoporous silica nanoparticles for efficient rivastigmine hydrogen tartrate delivery into SY5Y cells. Drug Dev Ind Pharm 43:628\u2013636. https:\/\/doi.org\/10.1080\/03639045.2016.1275668","journal-title":"Drug Dev Ind Pharm"},{"key":"3402_CR239","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/17425247.2016.1218464","volume":"14","author":"F Meng","year":"2017","unstructured":"Meng F, Han N, Yeo Y (2017) Organic nanoparticle systems for spatiotemporal control of multimodalchemotherapy. Expert Opin Drug Deliv 14:427. https:\/\/doi.org\/10.1080\/17425247.2016.1218464","journal-title":"Expert Opin Drug Deliv"},{"key":"3402_CR240","doi-asserted-by":"publisher","unstructured":"Petusseau AF, Bruza P, Pogue BW (2022) Protoporphyrin IX delayed fluorescence imaging: a modality for hypoxia-based surgical guidance. J Biomed Opt 27(10):106005. https:\/\/doi.org\/10.1117\/1.JBO.27.10.106005","DOI":"10.1117\/1.JBO.27.10.106005"},{"key":"3402_CR241","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/J.BMC.2017.11.024","volume":"26","author":"F Hammerer","year":"2018","unstructured":"Hammerer F, Poyer F, Fourmois L et al (2018) Mitochondria-targeted cationic porphyrin-triphenylamine hybrids for enhanced two-photon photodynamic therapy. Bioorganic Med Chem 26:107\u2013118. https:\/\/doi.org\/10.1016\/J.BMC.2017.11.024","journal-title":"Bioorganic Med Chem"},{"key":"3402_CR242","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1021\/ACS.JMEDCHEM.6B00408","volume":"59","author":"S Xu","year":"2016","unstructured":"Xu S, Luo S, Yao H et al (2016) Probing the anticancer action of oridonin with fluorescent analogues: visualizing subcellular localization to mitochondria. J Med Chem 59:5022\u20135034. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.6B00408","journal-title":"J Med Chem"},{"key":"3402_CR243","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/FBIOE.2021.720508\/BIBTEX","volume":"9","author":"Y Gao","year":"2021","unstructured":"Gao Y, Tong H, Li J et al (2021) Mitochondria-targeted nanomedicine for enhanced efficacy of cancer therapy. Front Bioeng Biotechnol 9:682. https:\/\/doi.org\/10.3389\/FBIOE.2021.720508\/BIBTEX","journal-title":"Front Bioeng Biotechnol"},{"key":"3402_CR244","doi-asserted-by":"publisher","unstructured":"Zorkina Y, Abramova O, Ushakova V et al (2020) Nano carrier drug delivery systems for the treatment of neuropsychiatric disorders: advantages and limitations. Molecules 25(22):5294. https:\/\/doi.org\/10.3390\/MOLECULES25225294","DOI":"10.3390\/MOLECULES25225294"},{"key":"3402_CR245","doi-asserted-by":"publisher","unstructured":"Khayal A, Dawane V, Amin MA et al (2021) Advances in the methods for the synthesis of Carbon dots and their emerging applications. Polymers (Basel) 13(18):3190. https:\/\/doi.org\/10.3390\/POLYM13183190","DOI":"10.3390\/POLYM13183190"},{"key":"3402_CR246","doi-asserted-by":"publisher","unstructured":"Saboktakin M (2019) Polymeric Nanoencapsulation of indocyanine green for photodynamic therapy technique. Am J Biomed Sci Res 3:35\u201348. https:\/\/doi.org\/10.34297\/AJBSR.2019.03.000630","DOI":"10.34297\/AJBSR.2019.03.000630"},{"key":"3402_CR247","doi-asserted-by":"publisher","unstructured":"Collins L, Binder P, Chen H, Wang X (2020) Regulation of long non-coding RNAs and MicroRNAs in heart disease: insight into mechanisms and therapeutic approaches. Front Physiol 11:798. https:\/\/doi.org\/10.3389\/FPHYS.2020.00798","DOI":"10.3389\/FPHYS.2020.00798"},{"key":"3402_CR248","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/FENDO.2018.00402\/BIBTEX","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 9:402. https:\/\/doi.org\/10.3389\/FENDO.2018.00402\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3402_CR249","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.116.303790","volume":"116","author":"T Saito","year":"2015","unstructured":"Saito T, Sadoshima J (2015) The molecular mechanisms of mitochondrial autophagy\/mitophagy in theheart. Circ Res 116:1477. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303790","journal-title":"Circ Res"},{"key":"3402_CR250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/FONC.2017.00065","volume":"7","author":"D Gozuacik","year":"2017","unstructured":"Gozuacik D, Akkoc Y, Gulfem Ozturk D, Kocak M (2017) Autophagy-regulating microRNAs and cancer. Front. Oncol 7:1. https:\/\/doi.org\/10.3389\/FONC.2017.00065","journal-title":"Oncol"},{"key":"3402_CR251","doi-asserted-by":"publisher","unstructured":"Zhou L, Liu S, Han M et al (2017) MicroRNA-185 induces potent autophagy via AKT signaling in hepatocellular carcinoma. Tumor Biol 39(2):1\u201313. https:\/\/doi.org\/10.1177\/1010428317694313","DOI":"10.1177\/1010428317694313"},{"key":"3402_CR252","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5607\/EN.2015.24.2.117","volume":"24","author":"J Song","year":"2015","unstructured":"Song J, Oh Y, Lee JE (2015) miR-Let7A modulates autophagy induction in LPS-activated microglia. Exp Neurobiol 24:117. https:\/\/doi.org\/10.5607\/EN.2015.24.2.117","journal-title":"Exp Neurobiol"},{"key":"3402_CR253","doi-asserted-by":"publisher","unstructured":"Dutta P, Haller E, Sharp A, Nanjundan M (2016) MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes. BMC Cancer 16(1):33. https:\/\/doi.org\/10.1186\/S12885-016-2053-3","DOI":"10.1186\/S12885-016-2053-3"},{"key":"3402_CR254","doi-asserted-by":"publisher","first-page":"17462","DOI":"10.18632\/AGING.203235","volume":"13","author":"J Yang","year":"2021","unstructured":"Yang J, Rao S, Cao R et al (2021) miR-30a-5p suppresses lung squamous cell carcinoma via ATG5 - mediated autophagy. Aging 9Albany NY) 13:17462. https:\/\/doi.org\/10.18632\/AGING.203235","journal-title":"Aging 9Albany NY)"},{"key":"3402_CR255","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/GUT.2004.042127","volume":"54","author":"L Xu","year":"2005","unstructured":"Xu L, Hui AY, Albanis E et al (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54:142. https:\/\/doi.org\/10.1136\/GUT.2004.042127","journal-title":"Gut"},{"key":"3402_CR256","doi-asserted-by":"publisher","unstructured":"Lan SH, Lin SC, Wang WC et al (2021) Autophagy upregulates miR-449a expression to suppress progression of colorectal cancer. Front Oncol 11:738144. https:\/\/doi.org\/10.3389\/FONC.2021.738144\/FULL","DOI":"10.3389\/FONC.2021.738144\/FULL"},{"key":"3402_CR257","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/15384047.2015.1040963","volume":"16","author":"N Huang","year":"2015","unstructured":"Huang N, Wu J, Qiu W et al (2015) MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of camptothecin. Cancer Biol Ther 16:941. https:\/\/doi.org\/10.1080\/15384047.2015.1040963","journal-title":"Cancer Biol Ther"},{"key":"3402_CR258","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.4161\/AUTO.24731","volume":"9","author":"L Tian","year":"2013","unstructured":"Tian L, Ma L, Guo E et al (2013) 20-Hydroxyecdysone upregulates Atg genes to induce autophagy in the Bombyx fat body. Autophagy 9:1172\u20131187. https:\/\/doi.org\/10.4161\/AUTO.24731","journal-title":"Autophagy"},{"key":"3402_CR259","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.3892\/IJMM.2018.3871\/HTML","volume":"42","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Zhang Y, Han L et al (2018) MiR-183 inhibits autophagy and apoptosis in gastric cancer cells by targeting ultraviolet radiation resistance-associated gene. Int J Mol Med 42:3562\u20133570. https:\/\/doi.org\/10.3892\/IJMM.2018.3871\/HTML","journal-title":"Int J Mol Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03402-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03402-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03402-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T09:35:24Z","timestamp":1691660124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03402-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":259,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["3402"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03402-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Both authors approved the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}